newsNew data for a microbiome-based therapeutic together with an immune…
29 May 2024 | By Catherine Eckford (European Pharmaceutical Review)
New data for a microbiome-based therapeutic together with an immune checkpoint inhibitor has shown “encouraging clinical benefits” in advanced cancers.